- Home
- ARBE vs SAVA Comparison
ARBE vs SAVA Comparison
Compare ARBE & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBE
- SAVA
- Stock Information
- Founded
- ARBE 2015
- SAVA 1998
- Country
- ARBE Israel
- SAVA United States
- Employees
- ARBE N/A
- SAVA N/A
- Industry
- ARBE EDP Services
- SAVA Biotechnology: Pharmaceutical Preparations
- Sector
- ARBE Technology
- SAVA Health Care
- Exchange
- ARBE Nasdaq
- SAVA Nasdaq
- Market Cap
- ARBE 124.2M
- SAVA 137.2M
- IPO Year
- ARBE N/A
- SAVA N/A
- Fundamental
- Price
- ARBE $1.04
- SAVA $1.38
- Analyst Decision
- ARBE Buy
- SAVA Buy
- Analyst Count
- ARBE 2
- SAVA 3
- Target Price
- ARBE $1.75
- SAVA $54.50
- AVG Volume (30 Days)
- ARBE 3.1M
- SAVA 2.2M
- Earning Date
- ARBE 05-21-2025
- SAVA 05-09-2025
- Dividend Yield
- ARBE N/A
- SAVA N/A
- EPS Growth
- ARBE N/A
- SAVA N/A
- EPS
- ARBE N/A
- SAVA N/A
- Revenue
- ARBE $768,000.00
- SAVA N/A
- Revenue This Year
- ARBE $398.05
- SAVA N/A
- Revenue Next Year
- ARBE $366.67
- SAVA N/A
- P/E Ratio
- ARBE N/A
- SAVA N/A
- Revenue Growth
- ARBE N/A
- SAVA N/A
- 52 Week Low
- ARBE $0.97
- SAVA $1.35
- 52 Week High
- ARBE $5.09
- SAVA $42.20
- Technical
- Relative Strength Index (RSI)
- ARBE 27.17
- SAVA 23.37
- Support Level
- ARBE $0.97
- SAVA $1.63
- Resistance Level
- ARBE $1.36
- SAVA $1.79
- Average True Range (ATR)
- ARBE 0.09
- SAVA 0.19
- MACD
- ARBE 0.02
- SAVA -0.14
- Stochastic Oscillator
- ARBE 13.42
- SAVA 1.76
About ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, USA, and others.
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.